Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 29
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » CONNEQT Health Limited (CQTHF) Q4 2026 Earnings Call Prepared Remarks Transcript
News

CONNEQT Health Limited (CQTHF) Q4 2026 Earnings Call Prepared Remarks Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 July 20263 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
CONNEQT Health Limited (CQTHF) Q4 2026 Earnings Call Prepared Remarks Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

Rod Hinchcliffe

Good morning, everyone, and welcome to CONNEQT Fourth Quarter Earnings Call for FY ’26. My name is Rod Hinchcliffe from M&C Partners. And with me on today’s call is CONNEQT Chief Executive Officer, Craig Cooper; Executive Chairman, Niall Cairns; and Chief Strategy Officer, Catherine Liao.

I’ll now pass the call over to Craig to lead today’s presentation.

Craig Cooper
Co-Founder, Group CEO, MD & Executive Director

Thanks, Rod. And sorry, everyone, for a little bit of a delay. We had a few technical difficulties. Welcome, everyone, to the CONNEQT Fourth Quarter Results Webinar. It’s reporting on our fourth consecutive strong quarter to end the year and a record quarter for our consumer business. We released our full results to the market yesterday, so I would encourage everyone to read the full ASX release, if you haven’t already done so. We also received questions by e-mail, so we’ll be trying to answer those as we go through the presentation.

This morning, I’ll start by outlining the financial and business for the quarter. Catherine Liao will then about our recent submission to the FDA and what that means further going forward. And then Niall Cairns will talk about recent fundraising, corporate activities and the current share purchase plan.

Okay. So let’s take a look at the quarter and the progress that we’ve made since we saw you in April. Next slide, Catherine. A couple of headlines that we’ll just call out, talk a little bit deeper about these as we move through. $1.3 million in consumer revenue, 71% from our digital product, 94,000

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

Zymeworks Inc. (ZYME) M&A Call Transcript

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

Dividend Announcements: September 19-25, 2026

Editors Picks

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

28 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.